RCEL
AVITA MedicalDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
RCEL vs peer average
50/100
RCEL vs. peer average (D vs. D)
Grade spread
C 3 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ARVN is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $477.32M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RCEL
AVITA Medical
ARVN
Arvinas
Grade
D
C
Momentum
100
23
Value
41
53
Sentiment
-
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ARVN
RCEL / ARVN
Grade Position
In line
RCEL vs. peer average (D vs. D)
50/100
Momentum
100
RCELValue
41
ARVNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RCEL
ARVN is the first peer returned for this comparison set.